medicine

Eligo Bioscience Awarded $5 Million to Advance Breakthrough Genetic Medicine Platform for Immuno-DermatologyEligo Bioscience Awarded $5 Million to Advance Breakthrough Genetic Medicine Platform for Immuno-Dermatology

Eligo Bioscience Awarded $5 Million to Advance Breakthrough Genetic Medicine Platform for Immuno-Dermatology

Funding is part of the call for proposals "Innovations in Biotherapies and Bioproduction," coordinated by the Health Innovation Agency under France…

4 days ago
HNL Lab Medicine Fuels Student SuccessHNL Lab Medicine Fuels Student Success

HNL Lab Medicine Fuels Student Success

ALLENTOWN, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- HNL Lab Medicine is proud to announce its partnership with South Mountain…

2 weeks ago
HNL Lab Medicine Announces 4th Annual Childrens Art ContestHNL Lab Medicine Announces 4th Annual Childrens Art Contest

HNL Lab Medicine Announces 4th Annual Childrens Art Contest

ALLENTOWN, Pa., May 01, 2025 (GLOBE NEWSWIRE) --  HNL Lab Medicine invites local artists in grades K–8 to enter its…

2 weeks ago
New data with daridorexant assessing the transition from night to day in insomnia disorder published in Sleep MedicineNew data with daridorexant assessing the transition from night to day in insomnia disorder published in Sleep Medicine

New data with daridorexant assessing the transition from night to day in insomnia disorder published in Sleep Medicine

Daridorexant improved sleep maintenance throughout the entire night, including the last quarter, while also improving next-morning sleepiness.Daridorexant improved next-morning sleepiness…

3 weeks ago
Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal MedicineAchieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine

Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine

April 21, 2025 11:19 ET  | Source: Achieve Life Sciences ORCA-3 Demonstrated a Significant Increase in Quitting and Reduction in…

4 weeks ago
Clearmind Medicine to Host Live Webinar Gazing Through the Crystal Ball Featuring Leading Psychedelic ExpertsClearmind Medicine to Host Live Webinar Gazing Through the Crystal Ball Featuring Leading Psychedelic Experts

Clearmind Medicine to Host Live Webinar Gazing Through the Crystal Ball Featuring Leading Psychedelic Experts

Vancouver, Canada, April 21, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

4 weeks ago
Declaration on longevity and precision medicine launched at Abu Dhabi Global Health WeekDeclaration on longevity and precision medicine launched at Abu Dhabi Global Health Week

Declaration on longevity and precision medicine launched at Abu Dhabi Global Health Week

Establishing actionable frameworks to advance precision medicine and longevity scienceThe declaration highlights the impact longevity and precision medicine can have…

4 weeks ago
Longevity and precision medicine driving the agenda at Abu Dhabi Global Health WeekLongevity and precision medicine driving the agenda at Abu Dhabi Global Health Week

Longevity and precision medicine driving the agenda at Abu Dhabi Global Health Week

Global initiative addressing personalised and preventative health to be launched during the eventABU DHABI, UAE, April 10, 2025 /PRNewswire/ -- With…

1 month ago
SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTCSOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC

SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC

BOSTON, MA and ROLLE, Switzerland, March 18, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader…

2 months ago
3D Systems Co-founder & Chief Technology Officer for Regenerative Medicine, Chuck Hull, Elected to the National Academy of Engineering3D Systems Co-founder & Chief Technology Officer for Regenerative Medicine, Chuck Hull, Elected to the National Academy of Engineering

3D Systems Co-founder & Chief Technology Officer for Regenerative Medicine, Chuck Hull, Elected to the National Academy of Engineering

ROCK HILL, S.C., Feb. 17, 2025 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE: DDD) announced Charles (Chuck) Hull, its co-founder…

3 months ago